Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells. [electronic resource]
Producer: 20180608ISSN:- 1573-4935
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Glyburide -- pharmacology
- Hep G2 Cells
- Humans
- Hypoglycemic Agents -- pharmacology
- Liver Neoplasms -- drug therapy
- MAP Kinase Signaling System -- drug effects
- Reactive Oxygen Species -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.